BG62930B1 - Селективни инхибитори на ароматазата, по-специално дифенилтриазолови производни - Google Patents

Селективни инхибитори на ароматазата, по-специално дифенилтриазолови производни Download PDF

Info

Publication number
BG62930B1
BG62930B1 BG99699A BG9969995A BG62930B1 BG 62930 B1 BG62930 B1 BG 62930B1 BG 99699 A BG99699 A BG 99699A BG 9969995 A BG9969995 A BG 9969995A BG 62930 B1 BG62930 B1 BG 62930B1
Authority
BG
Bulgaria
Prior art keywords
formula
compound
choh
cyanophenyl
pharmaceutically acceptable
Prior art date
Application number
BG99699A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG99699A (bg
Inventor
Arto J. Karjalainen
Marja-Liisa Soedervall
Arja M. Kalapudas
Reino O. Pelkonen
Aire M. Laine
Risto A. Lammintausta
Jarmo S. Salonen
Original Assignee
Risto Arvo Sakari Lammintausta
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Risto Arvo Sakari Lammintausta filed Critical Risto Arvo Sakari Lammintausta
Publication of BG99699A publication Critical patent/BG99699A/bg
Publication of BG62930B1 publication Critical patent/BG62930B1/bg

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/61Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms not forming part of a nitro radical, attached to ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/041,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pyridine Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
BG99699A 1992-12-16 1995-06-05 Селективни инхибитори на ароматазата, по-специално дифенилтриазолови производни BG62930B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9226209A GB2273704B (en) 1992-12-16 1992-12-16 Triazolyl diaryl selective aromatase inhibiting compounds
PCT/FI1993/000539 WO1994013645A1 (en) 1992-12-16 1993-12-14 Novel selective aromatase inhibiting compounds

Publications (2)

Publication Number Publication Date
BG99699A BG99699A (bg) 1996-04-30
BG62930B1 true BG62930B1 (bg) 2000-11-30

Family

ID=10726697

Family Applications (1)

Application Number Title Priority Date Filing Date
BG99699A BG62930B1 (bg) 1992-12-16 1995-06-05 Селективни инхибитори на ароматазата, по-специално дифенилтриазолови производни

Country Status (31)

Country Link
US (2) US5703109A (ru)
EP (1) EP0674626B1 (ru)
JP (1) JP3186771B2 (ru)
KR (1) KR100347639B1 (ru)
CN (1) CN1056835C (ru)
AT (1) ATE194833T1 (ru)
AU (1) AU682332B2 (ru)
BG (1) BG62930B1 (ru)
CA (1) CA2150904A1 (ru)
CZ (1) CZ283043B6 (ru)
DE (1) DE69329072T2 (ru)
DK (1) DK0674626T3 (ru)
EE (1) EE03155B1 (ru)
ES (1) ES2148312T3 (ru)
FI (1) FI952867A (ru)
GB (1) GB2273704B (ru)
GR (1) GR3034618T3 (ru)
HR (1) HRP931494B1 (ru)
IL (1) IL107714A (ru)
LT (1) LT3151B (ru)
NO (1) NO310237B1 (ru)
NZ (1) NZ258588A (ru)
PL (1) PL176413B1 (ru)
PT (1) PT674626E (ru)
RO (1) RO113986B1 (ru)
RU (1) RU2131418C1 (ru)
SI (1) SI9300663B (ru)
SK (1) SK281667B6 (ru)
TW (1) TW327169B (ru)
WO (1) WO1994013645A1 (ru)
ZA (1) ZA938717B (ru)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0891334A1 (en) * 1996-04-03 1999-01-20 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US6063930A (en) * 1996-04-03 2000-05-16 Merck & Co., Inc. Substituted imidazole compounds useful as farnesyl-protein transferase inhibitors
US6080870A (en) * 1996-04-03 2000-06-27 Merck & Co., Inc. Biaryl substituted imidazole compounds useful as farnesyl-protein transferase inhibitors
US5972921A (en) * 1997-12-12 1999-10-26 Hormos Medical Oy Ltd. Use of an aromatase inhibitor in the treatment of decreased androgen to estrogen ratio and detrusor urethral sphincter dyssynergia in men
EP1303270B1 (en) * 2000-07-10 2006-03-29 Hormos Medical Ltd. Method for treating cryptorchidism
FI20010905A0 (fi) * 2001-05-02 2001-05-02 Vetcare Oy Uusi eläinlääke
JP2005515207A (ja) * 2001-12-11 2005-05-26 エモリー ユニバーシティ 乳癌の予防において使用するためのビス(シアノフェニル)メチル−トリアゾール
EP1431292A1 (en) * 2002-12-16 2004-06-23 Laboratoire Theramex 1-N-phenylamino-1H-imidazole derivatives as aromatase inhibitors
JP2004196795A (ja) * 2002-12-16 2004-07-15 Wyeth 外部寄生虫駆除剤としてのn−フェニル−3−シクロプロピルピラゾール−4−カルボニトリル
US7345073B2 (en) 2003-02-07 2008-03-18 Hormos Medical Ltd. Method for treating cryptorchidism
US20040248989A1 (en) 2003-06-05 2004-12-09 Risto Santti Method for the treatment or prevention of lower urinary tract symptoms
CA2549603A1 (en) * 2003-12-15 2005-06-30 Laboratoire Theramex 1-n-phenyl-amino-1h-imidazole derivatives and pharmaceutical compositions containing them
MX2008014825A (es) * 2006-05-22 2008-12-01 Hormos Medical Ltd Moduladores selectivos del receptor de estrogeno o inhibidores de aromatasa para tratar prostatitis cronica no bacteriana.
GB0914767D0 (en) * 2009-08-24 2009-09-30 Sterix Ltd Compound
WO2011127232A2 (en) 2010-04-08 2011-10-13 Emory University Substituted androst-4-ene diones
JP5870093B2 (ja) * 2010-05-27 2016-02-24 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングBayer Intellectual Property GmbH 殺菌剤としてのヘテロ環式アルカノール誘導体
KR101583521B1 (ko) 2015-07-31 2016-01-08 (주) 엘림비엠에스 내오염, 내마모 성능과 시공 작업성 및 광도 성능이 개선된 피브이씨 타일 바닥의 코팅방법
US10905253B2 (en) 2018-04-19 2021-02-02 Wonderland Switzerland Ag Child carrier

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1580535A (en) * 1976-08-27 1980-12-03 Ici Ltd Substituted ketones and their use as herbicides
US4937250A (en) 1988-03-07 1990-06-26 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles
US5112845A (en) * 1986-03-07 1992-05-12 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles
US4978672A (en) 1986-03-07 1990-12-18 Ciba-Geigy Corporation Alpha-heterocyclc substituted tolunitriles
US5071861A (en) 1986-03-07 1991-12-10 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles
US4749713A (en) * 1986-03-07 1988-06-07 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles
AU627559B2 (en) * 1989-03-30 1992-08-27 Farmos-Yhtyma Oy Novel aromatase inhibiting 4(5)-imidazoles
DK0408509T3 (da) 1989-07-14 1996-04-01 Ciba Geigy Ag Substituerede benzonitriler
DE4039559A1 (de) * 1990-12-07 1992-06-11 Schering Ag Funktionalisierte vinylazole, verfahren zu deren herstellung, pharmazeutische praeparate die diese vinylazole enthalten sowie deren verwendung zur herstellung von arzneimitteln
GB9125924D0 (en) * 1991-06-18 1992-02-05 Orion Yhtymae Oy Stereoisomers of an imidazole derivative

Also Published As

Publication number Publication date
FI952867A0 (fi) 1995-06-09
GB2273704A (en) 1994-06-29
AU5652394A (en) 1994-07-04
JP3186771B2 (ja) 2001-07-11
HRP931494A2 (en) 1996-08-31
DE69329072D1 (de) 2000-08-24
HRP931494B1 (en) 2001-06-30
NO952365D0 (no) 1995-06-15
NO952365L (no) 1995-06-15
LT3151B (en) 1995-01-31
NZ258588A (en) 1996-11-26
SI9300663B (sl) 2002-02-28
JPH08504424A (ja) 1996-05-14
SK281667B6 (sk) 2001-06-11
LTIP1524A (en) 1994-07-15
TW327169B (en) 1998-02-21
KR950704263A (ko) 1995-11-17
IL107714A (en) 2003-07-31
NO310237B1 (no) 2001-06-11
CZ153295A3 (en) 1995-11-15
KR100347639B1 (ko) 2002-11-29
CN1056835C (zh) 2000-09-27
PT674626E (pt) 2000-11-30
EP0674626B1 (en) 2000-07-19
RU2131418C1 (ru) 1999-06-10
ZA938717B (en) 1994-06-30
GB9226209D0 (en) 1993-02-10
CZ283043B6 (cs) 1997-12-17
FI952867A (fi) 1995-06-09
SK77895A3 (en) 1995-12-06
SI9300663A (en) 1994-09-30
ATE194833T1 (de) 2000-08-15
GB2273704B (en) 1997-01-22
DE69329072T2 (de) 2000-12-21
CN1093357A (zh) 1994-10-12
PL176413B1 (pl) 1999-05-31
BG99699A (bg) 1996-04-30
RO113986B1 (ro) 1998-12-30
DK0674626T3 (da) 2000-11-13
EE03155B1 (et) 1999-02-15
WO1994013645A1 (en) 1994-06-23
CA2150904A1 (en) 1994-06-23
AU682332B2 (en) 1997-10-02
GR3034618T3 (en) 2001-01-31
ES2148312T3 (es) 2000-10-16
RU95114360A (ru) 1997-06-10
IL107714A0 (en) 1994-02-27
PL309350A1 (en) 1995-10-02
US5962495A (en) 1999-10-05
EP0674626A1 (en) 1995-10-04
US5703109A (en) 1997-12-30

Similar Documents

Publication Publication Date Title
BG62930B1 (bg) Селективни инхибитори на ароматазата, по-специално дифенилтриазолови производни
US5098923A (en) Aromatase inhibiting 4(5)-imidazoles
US6313311B1 (en) Imidazole derivatives having affinity for alpha2 receptors
Jones et al. Estrogen synthetase inhibitors. 2. Comparison of the in vitro aromatase inhibitory activity for a variety of nitrogen heterocycles substituted with diarylmethane or diarylmethanol groups
US6028202A (en) 1,5-diarylpyrazoles
SK279101B6 (sk) Spôsob výroby tolunitrilov substituovaných heteroc
US4363912A (en) Indole thromboxane synthetase inhibitors
SI9200113A (en) New selective aromatase inhibiting 4(5)-imidazoles
PL162513B1 (pl) Sposób wytwarzania nowych pochodnych i midazolu PL PL PL PL PL
EP0476944B1 (en) Aromatase inhibiting 4(5)-imidazoles
HUT72299A (en) Novel selective aromatase inhibiting heterocyclic compounds, pharmaceutical compositions containing them and process for preparing them
US3725432A (en) Biphenylyl pyrazole compounds
PL162554B1 (pl) S posób wytwarzania nowych pochodnych imidazolu PL PL PL PL PL